Stacey Ban, MD
Medical Director, Oncology and Specialty Drugs
Stacey Ban, MD, serves as the clinical lead for the AIM Medical Oncology and Specialty Drugs Solutions. In her role, she works closely with the executive leadership team to provide front line clinical expertise for the expansion of our integrated Oncology Solution including development of clinical pathways. Since joining AIM, she implemented solutions for Specialty Drugs and Radiation Therapy.
Prior to joining AIM, Dr. Ban was at the center of community-based oncology as an attending physician for a large private Hematology/Oncology practice in Chicago. During her tenure in clinical practice, she served on the hospital's Breast Cancer Advisory Committee, participated as a lecturer for the residency training program, and contributed as an investigator for several clinical trials.
She received her Bachelor of Science in Biology from the University of Michigan and her doctorate from Rush Medical College. She completed her residency at Rush University Medical Center. Dr. Ban is board certified in Medical Oncology and Hematology.